ArticleOncotarget2017

Rs7911488 modified the efficacy of capecitabine-based therapy in colon cancer through altering miR-1307-3p and TYMS expression.

Qi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.